Login / Signup
Irina Mirkina
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 3
Top Topics
Low Grade
Clinical Evaluation
Papillary Thyroid
Candida Albicans
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Alejandro A Puchol Tarazona
,
Alexander Schinagl
,
Irina Mirkina
,
Gregor Rossmueller
,
Randolf J Kerschbaumer
,
Friedmund Bachmann
,
Michael Thiele
Pretargeted radioimmunotherapy with the novel anti-oxMIF/HSG bispecific antibody ON105 results in significant tumor regression in murine models of cancer.
Molecular cancer therapeutics
(2024)
Alejandro A Puchol Tarazona
,
Alexander Schinagl
,
Irina Mirkina
,
Gregor Rossmueller
,
Randolf J Kerschbaumer
,
Friedmund Bachmann
,
Michael Thiele
Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer.
Molecular cancer therapeutics
(2024)
Gregor Rossmueller
,
Irina Mirkina
,
Barbara Maurer
,
Verena Hoeld
,
Julia Mayer
,
Michael Thiele
,
Randolf J Kerschbaumer
,
Alexander Schinagl
Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic.
Molecular cancer therapeutics
(2023)